Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: What Industry Needs to Know
Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: What Industry Needs to Know Presented by Lisa El-Shall and Jeb Hunter May 8, 2026 | 2:00 PM ET When the FDA issues a Form 483 at the conclusion of a drug CGMP inspection, your...
Overview of the Coming National Drug Code Format Change
Overview of the Coming National Drug Code Format Change Presented by Victoria Pankovich May 20, 2026 | 1:00 PM ET EAS Consulting Group is hosting a complimentary webinar, Overview of the Coming National Drug Code (NDC) Format Change. The FDA has finalized a rule...
Responding to Food and Seafood FDA 483s
Responding to Food and Seafood FDA 483s Presented by Mark Moen and Jeb Hunter May 19, 2026 | 2:00 PM ET When the FDA issues a Form 483 or Warning Letter, your response is critical—and time-sensitive. How you respond can directly impact regulatory outcomes, enforcement...
Food Safety Foundation: Developing a Risk-Based Supplier Approval Program
In this webinar, we will review the components of a risk-based supplier approval program to include (1) conducting a risk assessment, (2) conducting supplier verification, (3) ensuring adequate and proper documentation, and (4) implementing continuous improvement. Additionally, we will review supplier approval program requirements of the FDA and USDA and how these regulations compare some common 3rd party certification audit standards.
cGMP Responsibilities for Own Label Distributors and Brand Owners
This webinar will help you understand how to meet the requirements of an Own Label Distributor and comply with FDA regulations.